Caroli's disease classification: Difference between revisions
Jump to navigation
Jump to search
Agnesrinky (talk | contribs) |
Agnesrinky (talk | contribs) |
||
Line 16: | Line 16: | ||
:::* [[Renal]] [[cystic]] lesions also often occur | :::* [[Renal]] [[cystic]] lesions also often occur | ||
::* [[Hepatic]] function is preserved in most, but many patients have recurrent [[cholangitis]], [[liver]] [[abscesses]] and [[portal hypertension]]. | ::* [[Hepatic]] function is preserved in most, but many patients have recurrent [[cholangitis]], [[liver]] [[abscesses]] and [[portal hypertension]]. | ||
* The [[cysts]] are nonobstructive saccular or fusiform dilatations of the [[intrahepatic]] ducts. | * The [[cysts]] are nonobstructive [[saccular]] or [[fusiform]] dilatations of the [[intrahepatic]] ducts. | ||
* The disease may be unilobed or bilobed. Unilobed disease is most commonly localized to the left lobe of the [[liver]]. | * The disease may be unilobed or bilobed. Unilobed disease is most commonly localized to the left lobe of the [[liver]]. | ||
* Some reviews have reported that pure [[Caroli’s disease]] is not that common, and more patients actually have Type IVA disease, with both intra- and extra-hepatic [[cysts]]. | * Some reviews have reported that pure [[Caroli’s disease]] is not that common, and more patients actually have Type IVA disease, with both intra- and extra-hepatic [[cysts]]. | ||
* Intrahepatic [[biliary]] cystic disease should be differentiated from [[polycystic liver disease]], an autosomal dominant disorder characterized by cystic collections of [[serous]] fluid not in communication with the [[biliary tree]]. | * Intrahepatic [[biliary]] cystic disease should be differentiated from [[polycystic liver disease]], an autosomal dominant disorder characterized by cystic collections of [[serous]] fluid not in communication with the [[biliary tree]]. | ||
* The incidence of [[malignant]] transformation in intrahepatic cysts is ~7% in Caroli’s disease. | * The incidence of [[malignant]] transformation in intrahepatic [[cysts]] is ~7% in Caroli’s disease. | ||
==References== | ==References== |
Latest revision as of 20:04, 11 March 2022
Caroli's disease Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Caroli's disease classification On the Web |
American Roentgen Ray Society Images of Caroli's disease classification |
Risk calculators and risk factors for Caroli's disease classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Rinky Agnes Botleroo, M.B.B.S.
Classification
- Two subtypes of Caroli's disease have been described:
- Simple type
- As classically described, without cirrhosis or portal hypertension
- 60-80% associated with medullary sponge kidney
:* Periportal fibrosis type
- Also associated with:
- Congenital hepatic fibrosis – bland portal fibrosis, hyperproliferation of interlobular bile ducts within the portal areas, with variable shapes and size of bile ducts, and preservation of normal lobular architecture.
- Cirrhosis
- Portal hypertension (HTN)
- Esophageal varices
- Renal cystic lesions also often occur
- Hepatic function is preserved in most, but many patients have recurrent cholangitis, liver abscesses and portal hypertension.
- The cysts are nonobstructive saccular or fusiform dilatations of the intrahepatic ducts.
- The disease may be unilobed or bilobed. Unilobed disease is most commonly localized to the left lobe of the liver.
- Some reviews have reported that pure Caroli’s disease is not that common, and more patients actually have Type IVA disease, with both intra- and extra-hepatic cysts.
- Intrahepatic biliary cystic disease should be differentiated from polycystic liver disease, an autosomal dominant disorder characterized by cystic collections of serous fluid not in communication with the biliary tree.
- The incidence of malignant transformation in intrahepatic cysts is ~7% in Caroli’s disease.